Resistance training alters cytokine gene expression in skeletal muscle of adults with type 2 diabetes

International Journal of Immunopathology and Pharmacology

Volumn 19, Issue 4, 2006, Pages 739-749

  Gordon, P L ^a,b   Vannier, E ^a,c   Hamada, K ^a   Layne, J ^a   Hurley, B F ^b   Roubenoff, R ^a   Castaneda Sceppa, Carmen ^a  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

Inflammation; Muscle damage; Muscle hypertrophy; Strength training

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CD18 ANTIGEN; INSULIN; INTERLEUKIN 1BETA; METFORMIN; SULFONYLUREA DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; EXERCISE; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; MUSCLE BIOPSY; MUSCLE CELL; MUSCLE STRENGTH; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TRAINING; VASTUS LATERALIS MUSCLE;

EID: 33846437806     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200601900404     Document Type: Article

References (39)

1. Pickup J.C. 2004. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27:813.
2. Cheung A.T., D. Ree, J.K. Kills, J. Fuselier, D.H. Coy and M. Bryer-Ash. 1998. An in vivo model for elucidation of the mechanism of tumor necrosis factor-α (TNF-α)-induced insulin resistance: Evidence for differential regulation of insulin signaling by TNF-α. Endocrinology 139:4928.
3. Plomgaard P., K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J.R. Zierath and B.K. Pedersen. 2005. Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54:2939.
4. Spranger J., A. Kroke, M. Mohlig, K. Hoffmann, M.M. Bergmann, M. Ristow, H. Boeing and A.F.H. Pfeiffer. 2003. Inflammatory cytokines and the risk to develop type 2 Diabetes: Results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52:812.
5. O'Connor J.C., A. Satpathy, M.E. Hartman, E.M. Horvath, K.W. Kelley, R. Dantzer, R.W. Johnson and G.G. Freund. 2005. IL-1{beta}-mediated innate immunity Is amplified in the db/db mouse model of type 2 diabetes. J. Immunol. 174:4991.
6. Pickup J.C., M.B. Mattock, G.D. Chusney and D. Burt. 1997. NIDDM as a disease of the innate immune system: association of acute phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 40:1286.
7. Hotamisligil G.S., P. Arner, J.F. Caro, R.L. Atkinson and B.M. Spiegelman. 1995. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95:2409.
8. Saghizadeh M., J.M. Ong, W.T. Garvey, R.R. Henry and P.A. Kern. 1996. The expression of TNF-α by human muscle. J. Clin. Invest. 97:1111.
9. Garcia-Martinez C., N. Agell, M. Llovera, F.J. Lopez-Soriano and J.M. Argiles. 1993. Tumour necrosis factor-α increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett. 323:211.
10. Cooney R.N., S.R. Kimball and T.C. Vary. 1997. Regulation of skeletal muscle protein turnover during sepsis:mechanisms and mediators. Shock 7:1.
11. Pedersen M., H. Bruunsgaard, N. Weis, H.W. Hendel, B.U. Andreassen, E. Eldrup, F. Dela and B.K. Pedersen. 2003. Circulating levels of TNF-alpha and IL-6-relation to truncal fat mass and muscle mass in healthy elderly individuals and in patients with type-2 diabetes. Mech. Ageing Dev. 124:495.
12. Tidball J.G. 1995. Inflammatory cell response to acute muscle injury. Med. Sci. Sports Exerc. 27:1022.
13. Cone J.B. 2001. Inflammation. Am. J. Surg. 182:558.
14. Hamada K., E. Vannier, J.M. Sacheck, A.L. Witsell and R. Roubenoff. 2005. Senescence of human skeletal muscle impairs the local inflammatory cytokine response to accute eccentric exercise. Faseb. J. 19:264.
15. Fielding R.A., T.J. Manfredi, W. Ding, M.A. Fiatarone, W.J. Evans and J.G. Cannon. 1993. Acute phase response in exercise III. Neutrophil and IL-β accumulation in skeletal muscle. Am. J. Physiol. (Regulatory, Integrative and Comparative Physiology) 265:166.
16. Sakamoto K., K. Sakuma, K. Watanabe, T. Totsuka and K. Nosaka. 1998. IGF-I, bFGF and TGF(beta) immunoreactivities after eccentric contraction-induced muscle injury in vivo. Med. Sci. Sports Exerc. 30:104.
17. Greiwe J.S., B. Cheng, D.C. Rubin, K.E. Yarasheski and C.F. Semenkovich. 2001. Resistance exercise decreases skeletal muscle tumor necrosis factor-α in frail elderly humans. Faseb. J. 15:475.
18. Jozsi A.C., E.E. Dupont-Versteegden, J.M. Taylor-Jones, W.J. Evans, T.A. Trappe, W.W. Campbell and C.A. Peterson. 2000. Aged human muscle demonstrates an altered gene expression profile consistent with an impaired response to exercise. Mech. Ageing Dev. 120:45.
19. Ishii T., T. Yamakita, T. Sato, S. Tanaka and S. Fujii. 1998. Resistance training improves insulin sensitivity in NIDDM subjects without altering maximal oxygen uptake. Diabetes Care 21:1353.
20. Castaneda C., J.E. Layne, L. Munoz-Orians, P.L. Gordon, J. Walsmith, M. Foldvari, R. Roubenoff, K.L. Tucker and M.E. Nelson. 2002. A randomized controlled trial of resistance training to improve glycemic control in older adults with type 2 diabetes. Diabetes Care 25:2335.
21. Eriksson J., S. Taimela, K. Eriksson, S. Parviainen, J. Peltonen and U. Kujala. 1997. Resistance training in the treatment of non-insulin dependent diabetes mellitus. Int. J. Sports Med 18:242.
22. Sanchez-Madrid F., J.A. Nagy, E. Roggins, P. Simon and T.A. Springer. 1983. A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-I), the C3bi complement receptor (OKM1/Mac-1) and the p150,95 molecule. J. Exp. Med. 158:1785.
23. Fukuzawa M., J. Satoh, X. Qiang, S. Miyaguchi, Y. Sakata, T. Nakazawa, F. Ikehata, S. Ohta and T. Toyota. 1999. Inhibition of tumor necrosis factor-alpha with anti-diabetic agents. Diab. Res. Clin. Prac. 43:147.
24. Evans W.J., S.D. Phinney and V.R. Young. 1982. Suction applied to a muscle biopsy maximizes sample size. Medicine and Science in Sport and Exercise 14:101.
25. Padykula H.A. and E. Herman. 1955. Factors affecting the activity of adenosine triphosphatase and other phosphatases as measured by histochemical techniques. J. Histochem. Cytochem. 3:161.
26. Matthews D.R., J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher and R.C. Turner. 1985. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412.
27. Emoto M., Y. Nishizawa, K. Maekawa, Y. Hiura, H. Kanda, T. Kawagishi, T. Shoji, Y. Okuno and H. Morii. 1999. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 22:818.
28. Lohman T.G., A.F. Roche and R. Martorell. 1988 Anthropometric Standardization Reference Manual. Human Kinetic Books. Champaign, Illinois p. 1.
29. Miller J., R.E. Pratley, A.P. Goldberg, P. Gordon, M. Rubin, M.S. Trueth, A.S. Ryan and B.F. Hurley. 1994. Strength training increases insulin action in healthy 50-65 year old men. J. Appl. Physiol. 77:1122.
30. Cannon J.G., M.A. Fiatarone, R.A. Fielding and W.J. Evans. 1994. Aging and stress-induced changes in complement activation and neutrophil mobilization. J. Appl. Physiol. 76:2616.
31. Sporn M.B., A.B. Roberts, L.M. Wakefield and R.K. Assoian. 1986. The transforming growth factors-β: Biological function and chemical structure. Science 233:532.
32. Kjaer M. 2004. Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading. Physiol. Rev. 84:649.
33. Malmstrom J., G. Westergren-Thorsson and G. Marko-Varga. 2001. A proteomic approach to mimic fibrosis disease evolvement by an in vitro cell line. Electrophoresis 22:1776.
34. Goldberg A.L., J.D. Etlinger, D.F. Goldspink and C. Jablecki. 1975. Mechanisms of work-induced hypertrophy of skeletal muscle. Med. Sci. Sports Exerc. 7:248.
35. Wahl S.M., D.A. Hunt, L.M. Wakefield, N. McCartney-Francis, L.M. Wahl, A.B. Roberts and M.B. Sporn. 1987. Transforming growth factor-β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci., USA 84:5788.
36. Brandes M.E., U.E. Mai, K. Ohura and S. Wahl. 1991. Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta. J. Gerontol. Med. Sci. 147:1600.
37. Chen W. and S.M. Wahl. 1999. Manipulation of TGF-[beta] to control autoimmune and chronic inflammatory diseases. Microbes and Infection 1:1367.
38. Wahl S., H. Wong and N. McCartney-Francis. 1989. Role of growth factors in inflammation and repair. J. Cell Biochem. 40:93.
39. Manogue K.R., S.J.H. van Deventer and A. Cerami. 1991. Tumor necrosis factor alpha or cachectin, in The Cytokine Handbook, A.W. Thompson, ed. Academic Press, London, p.240.